Amgen Inc (AMGN)

$410.95 +6.10 (1.51%)
Market Cap 222.17B
Revenue (ttm) 36.75B
Net Income (ttm) 7.71B
EPS (ttm) N/A
PE Ratio 18.10
Forward PE 17.81
Profit Margin 20.98%
Debt to Equity Ratio 6.24
Volume 1,821,500
Avg Vol 2,802,538
Day's Range N/A - N/A
Shares Out 540.63M
Stochastic %K 82%
Beta 0.41
Analysts Sell
Price Target $382.39

Company Profile

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of my...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 805 447 1000
Fax: 805 447 1010
Address:
One Amgen Center Drive, Thousand Oaks, United States
StockNavigator_
StockNavigator_ Aug. 9 at 3:18 PM
How Every Dow Jones Stock Has Performed in 2026 📊 （Part 1） Here are the early leaders so far: $CSCO +57.6% 🟢 $CAT +47.0% 🟢 $TRV +32.5% 🟢 $AMGN +25.6% 🟢 $JNJ +25.3% 🟢 Interesting to see how much strength has come from a mix of tech, industrials, insurance and healthcare rather than just the usual mega-cap names. I’m watching the next group closely for signs of continued momentum or potential rotation. The next setup is already taking shape. Stay connected.
1 · Reply
JuanitaBayas230
JuanitaBayas230 Aug. 9 at 2:33 PM
$IBM $SAP $NVO $AMGN $SAN IBM expands enterprise AI and hybrid cloud, SAP leads enterprise software, Novo Nordisk dominates obesity treatments, Amgen advances biotechnology, and Banco Santander benefits from international banking.
0 · Reply
EquityVoyager_1
EquityVoyager_1 Aug. 9 at 2:15 PM
DOW 2026 PERFORMANCE CHECK Here are the standout Dow names so far this year: $CSCO +57.6% $CAT +47.0% $TRV +32.5% $AMGN +25.6% $JNJ +25.3% The Dow’s leadership is showing some serious strength. Which one do you think still has the most room to run? Another alert is coming soon. If notifications are off, chances are you’ll only notice the move once it’s already in progress.
0 · Reply
RaymondCleveland696
RaymondCleveland696 Aug. 9 at 11:34 AM
$IBM $SAP $NVO $AMGN $SAN IBM expands enterprise AI and hybrid cloud, SAP leads enterprise software, Novo Nordisk dominates obesity treatments, Amgen advances biotechnology, and Banco Santander benefits from international banking.
0 · Reply
clan
clan Aug. 8 at 10:44 AM
$MNKD ❔️ The question is not, "What is Mannkind?" The answer to, "Who is Mannkind?" is ... It's a conglomerate of support networks, advocates, and partnerships, successfully working together to bring medical solutions to patients, young and old, so they may live life more humann. $IBB $MRK $AMGN
0 · Reply
Reanimated666
Reanimated666 Aug. 7 at 4:39 PM
$AMGN Gigantic fantastic performance
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 7 at 4:01 PM
$AMGN printed a new 52-week high today
0 · Reply
judgeyoung2
judgeyoung2 Aug. 7 at 3:07 AM
$AMGN not sure what to think… did it break $400 or this a tease ? All I know is if it sees $390 again then it’s probably seeing lower than that.
0 · Reply
rayzuran
rayzuran Aug. 7 at 2:31 AM
$AMGN what’s the word on them refusing to comply with the FDA? Not smart if they plan on getting any more drugs approved in the US.
0 · Reply
ILuvbiotech
ILuvbiotech Aug. 6 at 7:46 PM
$NWBO Lp was approached by $AMGN founder and he funded some of her research. Amgen is worth 220B.
1 · Reply
Latest News on AMGN
Amgen price target raised to $405 from $345 at Citi

2026-08-07T10:46:04.000Z - 2 days ago

Amgen price target raised to $405 from $345 at Citi

Amgen price target raised to $345 from $335 at Bernstein

2026-08-06T11:57:03.000Z - 3 days ago

Amgen price target raised to $345 from $335 at Bernstein

Amgen price target raised to $450 from $385 at Scotiabank

2026-08-05T15:05:45.000Z - 4 days ago

Amgen price target raised to $450 from $385 at Scotiabank

Amgen price target raised to $362 from $340 at Truist

2026-08-05T14:11:35.000Z - 4 days ago

Amgen price target raised to $362 from $340 at Truist

Amgen price target raised to $440 from $420 at UBS

2026-08-05T14:01:43.000Z - 4 days ago

Amgen price target raised to $440 from $420 at UBS

Amgen price target raised to $452 from $420 at TD Cowen

2026-08-05T13:54:09.000Z - 4 days ago

Amgen price target raised to $452 from $420 at TD Cowen

Amgen price target raised to $450 from $400 at Oppenheimer

2026-08-05T11:51:16.000Z - 4 days ago

Amgen price target raised to $450 from $400 at Oppenheimer

Amgen price target raised to $351 from $333 at Morgan Stanley

2026-08-05T11:41:37.000Z - 4 days ago

Amgen price target raised to $351 from $333 at Morgan Stanley

NVS

Amgen price target raised to $400 from $370 at RBC Capital

2026-08-05T11:38:15.000Z - 4 days ago

Amgen price target raised to $400 from $370 at RBC Capital

Amgen price target raised to $317 from $312 at BofA

2026-08-05T11:33:31.000Z - 4 days ago

Amgen price target raised to $317 from $312 at BofA

Amgen price target raised to $230 from $215 at Baird

2026-08-05T11:30:32.000Z - 4 days ago

Amgen price target raised to $230 from $215 at Baird

Amgen price target raised to $384 from $366 at Canaccord

2026-08-05T11:07:10.000Z - 4 days ago

Amgen price target raised to $384 from $366 at Canaccord

Amgen price target raised to $450 from $400 at BMO Capital

2026-08-05T10:52:14.000Z - 4 days ago

Amgen price target raised to $450 from $400 at BMO Capital

Amgen price target raised to $400 from $390 at Wells Fargo

2026-08-05T10:51:30.000Z - 4 days ago

Amgen price target raised to $400 from $390 at Wells Fargo

Amgen Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 days ago

Amgen Earnings Call Transcript: Q2 2026

Amgen Earnings release: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 days ago

Amgen Earnings release: Q2 2026

Amgen Slides: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 days ago

Amgen Slides: Q2 2026

Amgen Quarterly report: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 days ago

Amgen Quarterly report: Q2 2026

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment

Aug 4, 2026, 4:14 PM EDT - 5 days ago

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment

Amgen reports Q2 adjusted EPS $6.29, consensus $5.62

2026-08-04T20:07:12.000Z - 5 days ago

Amgen reports Q2 adjusted EPS $6.29, consensus $5.62

Amgen raises FY26 adjusted EPS view to $22.30-$23.50 from $21.70-$23.10

2026-08-04T20:06:36.000Z - 5 days ago

Amgen raises FY26 adjusted EPS view to $22.30-$23.50 from $21.70-$23.10

Amgen second-quarter sales rise 9%, profit tops Street view

Aug 4, 2026, 4:04 PM EDT - 5 days ago

Amgen second-quarter sales rise 9%, profit tops Street view

AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Aug 4, 2026, 4:01 PM EDT - 5 days ago

AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Amgen discloses data breach, says patient information was stolen

Jul 31, 2026, 4:13 PM EDT - 9 days ago

Amgen discloses data breach, says patient information was stolen

Amgen says cybersecurity incident not likely to have material impact

2026-07-31T20:10:27.000Z - 9 days ago

Amgen says cybersecurity incident not likely to have material impact

AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND

Jul 30, 2026, 4:01 PM EDT - 10 days ago

AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND

Amgen price target raised to $360 from $350 at Barclays

2026-07-29T09:10:53.000Z - 11 days ago

Amgen price target raised to $360 from $350 at Barclays

AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS

Jul 28, 2026, 4:45 PM EDT - 12 days ago

AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS

Amgen submits new data to challenge FDA's proposal to withdraw Tavneos

Jul 24, 2026, 9:45 AM EDT - 16 days ago

Amgen submits new data to challenge FDA's proposal to withdraw Tavneos

Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill

Jul 21, 2026, 11:10 AM EDT - 19 days ago

Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill

Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel

Jul 1, 2026, 4:47 PM EDT - 5 weeks ago

Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel

Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings

Jun 29, 2026, 4:46 PM EDT - 5 weeks ago

Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

Jun 26, 2026, 8:26 AM EDT - 6 weeks ago

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug

Jun 26, 2026, 7:10 AM EDT - 6 weeks ago

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug

The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 7 weeks ago

The Healthcare M&A Wave

ABT ALNY AMRX ANTX AZN BDX BEAM

Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape

Jun 14, 2026, 8:01 PM EDT - 7 weeks ago

Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape

Drugmakers race to find a place in the next wave of obesity drugs

Jun 13, 2026, 8:00 AM EDT - 2 months ago

Drugmakers race to find a place in the next wave of obesity drugs

NVO AZN LLY

Amgen taps research firm to reassess Tavneos data

Jun 11, 2026, 7:28 PM EDT - 2 months ago

Amgen taps research firm to reassess Tavneos data

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

Jun 11, 2026, 7:14 AM EDT - 2 months ago

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

ABBV ALKS GILD IBB IHE JNJ KYMR

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

JNJ LLY MRK NVO PFE

Amgen Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Amgen Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

Jun 7, 2026, 4:45 PM EDT - 2 months ago

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

Jun 4, 2026, 4:01 PM EDT - 2 months ago

AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

Amgen Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 9:55 AM EDT - 2 months ago

Amgen Transcript: Jefferies Global Healthcare Conference 2026

AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

Jun 3, 2026, 9:00 AM EDT - 2 months ago

AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

May 29, 2026, 4:01 PM EDT - 2 months ago

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

This Boring Income Portfolio Strategy Could Unlock 300%+ Upside

May 27, 2026, 11:45 AM EDT - 2 months ago

This Boring Income Portfolio Strategy Could Unlock 300%+ Upside

V

Ember LifeSciences announces new strategic investments boosting Series A to $27M

May 27, 2026, 9:00 AM EDT - 2 months ago

Ember LifeSciences announces new strategic investments boosting Series A to $27M

Doctors in Japan can again prescribe an Amgen rare-disease drug to new patients, reversing a recommendation made only days ago following 20 deaths

May 21, 2026, 6:24 AM EDT - 2 months ago

Doctors in Japan can again prescribe an Amgen rare-disease drug to new patients, reversing a recommendation made only days ago following 20 deaths

Amgen says CFO Peter Griffith to retire, names Dittrich as successor

May 19, 2026, 5:20 PM EDT - 2 months ago

Amgen says CFO Peter Griffith to retire, names Dittrich as successor

AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH

May 19, 2026, 4:05 PM EDT - 2 months ago

AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH

Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports

May 15, 2026, 4:16 PM EDT - 3 months ago

Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports

Twenty people in Japan who took an Amgen rare immune-disease drug have died, according to the company that sells the medicine in Japan. U.S. drug regulators had asked Amgen to voluntarily withdraw the drug.

May 15, 2026, 3:37 PM EDT - 3 months ago

Twenty people in Japan who took an Amgen rare immune-disease drug have died, according to the company that sells the medicine in Japan. U.S. drug regulators had asked Amgen to voluntarily withdraw the drug.

Amgen Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 1:00 PM EDT - 3 months ago

Amgen Transcript: Bank of America Global Healthcare Conference 2026

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

May 7, 2026, 4:01 PM EDT - 3 months ago

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

Amgen to invest additional $300 million to boost US manufacturing footprint

May 4, 2026, 9:42 AM EDT - 3 months ago

Amgen to invest additional $300 million to boost US manufacturing footprint

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

May 4, 2026, 9:00 AM EDT - 3 months ago

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

Amgen Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Amgen Earnings Call Transcript: Q1 2026

Amgen Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Amgen Slides: Q1 2026

Amgen Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Amgen Earnings release: Q1 2026

Amgen Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Amgen Quarterly report: Q1 2026

Amgen Posts Higher First-Quarter Profit, Revenue

Apr 30, 2026, 4:19 PM EDT - 3 months ago

Amgen Posts Higher First-Quarter Profit, Revenue

Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug

Apr 30, 2026, 4:06 PM EDT - 3 months ago

Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug

AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

Apr 30, 2026, 4:01 PM EDT - 3 months ago

AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

FDA proposes to withdraw Amgen's rare autoimmune disease drug

Apr 27, 2026, 9:04 PM EDT - 3 months ago

FDA proposes to withdraw Amgen's rare autoimmune disease drug

Pharma bets a little-known cholesterol will underpin its next blockbuster heart drugs

Apr 27, 2026, 12:55 PM EDT - 3 months ago

Pharma bets a little-known cholesterol will underpin its next blockbuster heart drugs

NVS LLY

AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS

Apr 24, 2026, 4:01 PM EDT - 3 months ago

AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS

AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER

Apr 22, 2026, 4:00 PM EDT - 3 months ago

AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER

Amgen Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Amgen Proxy statement: Proxy filing

Amgen Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 months ago

Amgen Proxy statement: Proxy filing

Amgen's lung cancer drug tarlatamab wins China approval

Apr 10, 2026, 4:10 AM EDT - 4 months ago

Amgen's lung cancer drug tarlatamab wins China approval

15 stocks to put on your list to buy when the market recovers

Apr 7, 2026, 2:54 PM EDT - 4 months ago

15 stocks to put on your list to buy when the market recovers

ADBE BMY CVS KNSL MS NVDA TGT

Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.

Apr 6, 2026, 12:10 PM EDT - 4 months ago

Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.

VRDN

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE

Apr 6, 2026, 9:00 AM EDT - 4 months ago

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE

Swiss industry body says US tariffs on pharmaceuticals will harm patients

Apr 3, 2026, 11:08 AM EDT - 4 months ago

Swiss industry body says US tariffs on pharmaceuticals will harm patients

ABBV AZN BMY MRK NVO

Trump Administration Unveils Up to 100% Tariff on Branded Drugs

Apr 2, 2026, 5:34 PM EDT - 4 months ago

Trump Administration Unveils Up to 100% Tariff on Branded Drugs

AZN NVO ABBV BMY MRK

Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices

Apr 2, 2026, 5:33 PM EDT - 4 months ago

Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices

ABBV AZN BMY MRK NVO

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

Apr 2, 2026, 3:29 PM EDT - 4 months ago

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

AZN NVO ABBV BMY MRK

Global pharma companies that have publicly announced Trump drug pricing agreements

Apr 2, 2026, 2:59 PM EDT - 4 months ago

Global pharma companies that have publicly announced Trump drug pricing agreements

ABBV AZN BMY MRK

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

Apr 1, 2026, 7:30 AM EDT - 4 months ago

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

ZLAB

FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths

Mar 31, 2026, 11:16 AM EDT - 4 months ago

FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths

StockNavigator_
StockNavigator_ Aug. 9 at 3:18 PM
How Every Dow Jones Stock Has Performed in 2026 📊 （Part 1） Here are the early leaders so far: $CSCO +57.6% 🟢 $CAT +47.0% 🟢 $TRV +32.5% 🟢 $AMGN +25.6% 🟢 $JNJ +25.3% 🟢 Interesting to see how much strength has come from a mix of tech, industrials, insurance and healthcare rather than just the usual mega-cap names. I’m watching the next group closely for signs of continued momentum or potential rotation. The next setup is already taking shape. Stay connected.
1 · Reply
JuanitaBayas230
JuanitaBayas230 Aug. 9 at 2:33 PM
$IBM $SAP $NVO $AMGN $SAN IBM expands enterprise AI and hybrid cloud, SAP leads enterprise software, Novo Nordisk dominates obesity treatments, Amgen advances biotechnology, and Banco Santander benefits from international banking.
0 · Reply
EquityVoyager_1
EquityVoyager_1 Aug. 9 at 2:15 PM
DOW 2026 PERFORMANCE CHECK Here are the standout Dow names so far this year: $CSCO +57.6% $CAT +47.0% $TRV +32.5% $AMGN +25.6% $JNJ +25.3% The Dow’s leadership is showing some serious strength. Which one do you think still has the most room to run? Another alert is coming soon. If notifications are off, chances are you’ll only notice the move once it’s already in progress.
0 · Reply
RaymondCleveland696
RaymondCleveland696 Aug. 9 at 11:34 AM
$IBM $SAP $NVO $AMGN $SAN IBM expands enterprise AI and hybrid cloud, SAP leads enterprise software, Novo Nordisk dominates obesity treatments, Amgen advances biotechnology, and Banco Santander benefits from international banking.
0 · Reply
clan
clan Aug. 8 at 10:44 AM
$MNKD ❔️ The question is not, "What is Mannkind?" The answer to, "Who is Mannkind?" is ... It's a conglomerate of support networks, advocates, and partnerships, successfully working together to bring medical solutions to patients, young and old, so they may live life more humann. $IBB $MRK $AMGN
0 · Reply
Reanimated666
Reanimated666 Aug. 7 at 4:39 PM
$AMGN Gigantic fantastic performance
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 7 at 4:01 PM
$AMGN printed a new 52-week high today
0 · Reply
judgeyoung2
judgeyoung2 Aug. 7 at 3:07 AM
$AMGN not sure what to think… did it break $400 or this a tease ? All I know is if it sees $390 again then it’s probably seeing lower than that.
0 · Reply
rayzuran
rayzuran Aug. 7 at 2:31 AM
$AMGN what’s the word on them refusing to comply with the FDA? Not smart if they plan on getting any more drugs approved in the US.
0 · Reply
ILuvbiotech
ILuvbiotech Aug. 6 at 7:46 PM
$NWBO Lp was approached by $AMGN founder and he funded some of her research. Amgen is worth 220B.
1 · Reply
IncelBull
IncelBull Aug. 6 at 1:36 PM
$LULU women and the LGBTQ community will be buying new yogapants as they are using GLP1s from $NVO and $PFE $LLY $AMGN
2 · Reply
albiegf13
albiegf13 Aug. 5 at 8:23 PM
$AMGN NEW ALL TIME HIGH TODAY...
0 · Reply
NEWBIGTECH
NEWBIGTECH Aug. 5 at 4:58 PM
$SLS $IBRX $PFE $MRK $AMGN
0 · Reply
albiegf13
albiegf13 Aug. 5 at 4:45 PM
$IBRX New all time high on $AMGN...!
0 · Reply
StocksandSuds
StocksandSuds Aug. 5 at 3:54 PM
SELLAS! SLS! 💵💵💵💵💵 $AMGN $IBRX $MRK $PFE $SLS
0 · Reply
tommy45
tommy45 Aug. 5 at 3:44 PM
$SLS $IBRX $PFE $MRK $AMGN
0 · Reply
tommy45
tommy45 Aug. 5 at 3:42 PM
$SLS $IBRX $PFE $MRK $AMGN
0 · Reply
Cutlass
Cutlass Aug. 5 at 2:45 PM
$AMGN 💥
0 · Reply
Dmac62177
Dmac62177 Aug. 5 at 2:45 PM
$AMGN
0 · Reply
RealTradeJournal
RealTradeJournal Aug. 5 at 2:43 PM
Dow just ripped another +650 pts. Leadership is getting broader, not weaker. $AMGN pushing higher $CAT +2.5% $GS +1.8% $NVDA +4.5% This kind of participation is exactly what keeps momentum alive. Bulls are still in control until the market proves otherwise. The next setup is developing. Stay alert before the market makes its move.
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 5 at 2:31 PM
$AMGN printed a new 52-week high today
0 · Reply
chartistmind
chartistmind Aug. 5 at 2:08 PM
$AMGN up 29% ytd. Every fkn year, i nail the stock of the year in the $DIA but somehow i can’t seem to figure out this damn scam ticker $SPY 🤦🏻‍♂️ 🤦‍♀️ 🤦
0 · Reply